G&E Herbal Biotechnology Co., Ltd. (4911.TWO)
TWD 49.25
(-9.96%)
TWD 49.25
(-9.96%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 99.83 Million TWD | 500.49% |
| 2022 | 16.62 Million TWD | 262.62% |
| 2021 | -10.22 Million TWD | -63.35% |
| 2020 | -6.26 Million TWD | 65.78% |
| 2019 | -19.45 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 32.03 Million TWD | 18.02% |
| 2024 Q1 | 27.13 Million TWD | 11.07% |
| 2023 Q4 | 34.25 Million TWD | 53.7% |
| 2023 Q3 | 22.28 Million TWD | -3.72% |
| 2023 FY | - TWD | 500.49% |
| 2023 Q2 | 23.14 Million TWD | 9.36% |
| 2023 Q1 | 21.16 Million TWD | 48200.0% |
| 2022 Q4 | -44 Thousand TWD | 0.0% |
| 2022 FY | - TWD | 262.62% |
| 2021 FY | - TWD | -63.35% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 315.892% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 74.635% |
| Level Biotechnology Inc. | 98.7 Million TWD | -1.148% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 323.154% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 238.441% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 495.66% |
| GlycoNex Incorporation | -126.82 Million TWD | 178.719% |
| VBI | -6.97 Million TWD | 1531.971% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 169.478% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -357.758% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 663.224% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 196.354% |
| Visgeneer Inc. | 973 Thousand TWD | -10160.74% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 129.409% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 89.339% |
| Neith Corporation | -33.61 Million TWD | 397.046% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 110.073% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 5847.668% |
| Enimmune corporation | -228.96 Million TWD | 143.604% |
| TaiRx, Inc. | -208.64 Million TWD | 147.85% |
| CHO Pharma, Inc. | -277.73 Million TWD | 135.947% |
| EirGenix Inc. | -664.4 Million TWD | 115.027% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -35.09% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | -44.392% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 109.318% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 188.269% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -186.575% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 260.147% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 479.608% |
| RBC Bioscience Corporation | 36.54 Million TWD | -173.174% |
| BiOptic Inc. | 65.03 Million TWD | -53.506% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 114.629% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 402.481% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 281.803% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 76.973% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 224.684% |
| NaviFUS Corp. | -55.79 Million TWD | 278.935% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 701.5% |
| Sinew Pharma Inc. | -163.63 Million TWD | 161.013% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 262.337% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 48.11% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 144.044% |
| AP Biosciences Inc | -325.51 Million TWD | 130.671% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 109.557% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 378.516% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -242.729% |
| Intech Biopharm Corporation | -219.58 Million TWD | 145.466% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 114.808% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 322.102% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 162.066% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 84.77% |
| TCI GENE Inc. | 25.98 Million TWD | -284.269% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 190.238% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 135.181% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 168.396% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -620.845% |
| PharmaEngine, Inc. | 347.3 Million TWD | 71.254% |
| Savior Lifetec Corporation | 219.6 Million TWD | 54.538% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 42.033% |
| OBI Pharma, Inc. | -855.08 Million TWD | 111.676% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 207.858% |
| Acepodia, Inc. | -764.51 Million TWD | 113.059% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 121.699% |